ESC Premium Access

Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea

Congress Presentation

About the speaker

Doctor Frederik Dalgaard

Gentofte University Hospital, Gentofte (Denmark)
0 follower

9 more presentations in this session

Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)

Thumbnail

Left ventricular stiffness assessed by diastolic wall strain predicts infrequent atrial fibrillation

Speaker: Doctor H. Kishima (Hyogo, JP)

Thumbnail

Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)

Speaker: Doctor H. Arshad (Newark, US)

Thumbnail

The impact of elective cardioversion for atrial fibrillation in heart failure patients

Speaker: Doctor J. Graby (Bath, GB)

Thumbnail

Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

Speaker: Professor R. Dabrowski (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Speakers: Doctor F. Dalgaard, Associate Professor M. Dzeshka, Doctor H. Kishima, Doctor H. Arshad, Doctor J. Graby...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk